Oragenics, Inc.

OGEN · AMEX
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$865$3,484$11,427$27,266
Short-Term Investments$0$0$0$0
Receivables$0$0$0$7
Inventory$0$0$0$0
Other Curr. Assets$608$382$2,863$435
Total Curr. Assets$1,473$3,866$14,290$27,707
Property Plant & Equip (Net)$0$10$469$524
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$1,091$0$0
Total NC Assets$0$1,101$469$524
Other Assets$0$0$0$0
Total Assets$1,473$4,966$14,758$28,231
Liabilities
Payables$1,145$1,245$247$855
Short-Term Debt$329$323$472$498
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$211$231$878$93
Total Curr. Liab.$1,684$1,798$1,596$1,445
LT Debt$0$0$152$300
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$0$0$152$300
Other Liabilities$0$0$0$0
Cap. Leases$0$10$357$494
Total Liabilities$1,684$1,798$1,749$1,745
Equity
Pref Stock$0$1,593$1,593$2,657
Common Stock$13$3$2$116
Retained Earnings-$216,786-$206,218-$185,563-$171,274
AOCI$0$0$0$0
Other Equity$216,562$207,791$196,977$194,987
Total Equity-$212$3,168$13,009$26,486
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,473$4,966$14,758$28,231
Net Debt-$536-$3,161-$10,802-$26,468